ScoreWhy is Hester Biosciences Ltd ?
1
Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.73 times
- Poor long term growth as Net Sales has grown by an annual rate of 10.17% and Operating profit at 4.72% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.73 times
- The company has been able to generate a Return on Capital Employed (avg) of 9.10% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 10.17% and Operating profit at 4.72% over the last 5 years
3
With ROCE of 7.7, it has a Very Expensive valuation with a 2.7 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -23.17%, its profits have risen by 31.5% ; the PEG ratio of the company is 1
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Hester Bios for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Hester Bios
-22.87%
-0.51
44.61%
Sensex
5.37%
0.47
11.36%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.17%
EBIT Growth (5y)
4.72%
EBIT to Interest (avg)
5.30
Debt to EBITDA (avg)
3.87
Net Debt to Equity (avg)
0.61
Sales to Capital Employed (avg)
0.55
Tax Ratio
22.04%
Dividend Payout Ratio
21.66%
Pledged Shares
0
Institutional Holding
0.52%
ROCE (avg)
9.34%
ROE (avg)
11.93%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
32
Price to Book Value
3.76
EV to EBIT
27.17
EV to EBITDA
20.66
EV to Capital Employed
2.72
EV to Sales
4.70
PEG Ratio
0.99
Dividend Yield
0.47%
ROCE (Latest)
7.69%
ROE (Latest)
12.97%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
PBT LESS OI(Q)
At Rs 12.85 cr has Grown at 131.12%
ROCE(HY)
Highest at 10.91%
DEBT-EQUITY RATIO(HY)
Lowest at 0.63 times
PAT(9M)
Higher at Rs 39.66 Cr
NET SALES(Q)
At Rs 77.42 cr has Grown at 22.46%
-3What is not working for the Company
PAT(Q)
At Rs 8.77 cr has Fallen at -24.8%
Loading Valuation Snapshot...
Here's what is working for Hester Bios
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 12.85 cr has Grown at 131.12%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Debt-Equity Ratio - Half Yearly
Lowest at 0.63 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Sales - Quarterly
At Rs 77.42 cr has Grown at 22.46%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Hester Bios
Profit After Tax (PAT) - Quarterly
At Rs 8.77 cr has Fallen at -24.8%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
